Three major cancer hospitals enter the collaboration for the first time for the research on “Integrated Cancer Clinical Database” developed by the Japanese Foundation for Cancer Research, aiming at its social implementation for drug development in Japan (November, 2024)

2024/11/26
Shizuoka Cancer Center

The Japanese Foundation for Cancer Research Ariake Hospital has initiated the research “B-1: Social Implementation of Integrated Clinical Database for Cancer Care,” which is one of the projects for the “Cross-Ministerial Strategic Innovation Promotion Program (SIP),” a research development program of the Cabinet Office. In November, 2024, the JFCR announced that they entered the collaboration with 3 leading cancer hospitals in Japan, the Aichi Cancer Center, the Shizuoka Cancer Center, and the Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, for the first time. Since 2017, the JFCR Ariake Hospital has uniquely developed the “integrated cancer clinical database” to build a unified data management system for importing data automatically or semi-automatically, which were once dispersed across various database including electronic medical chart and sectionally-independent electronic systems. It doesn’t only enable the unification of in-hospital data management, but also the application of the data for drug development, which is expected to be made swift and efficient through coordination with pharmaceutical companies. Since this is a multi-institutional project, the more medical institutions participate in it, the bigger the database becomes integrating the clinical data from each hospital. In addition, while searching the clinical data for recruiting potential participants for global clinical trials used to be done manually in weeks, now it takes only some minutes to narrow them down across the database. It is expected to accelerate clinical trial matching, and to enhance Japanese drug and medical equipment developments through utilizing ample clinical data. 

 

Topics

Topics